End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.47 CNY | +3.06% | +1.71% | +24.33% |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- With a P/E ratio at 12.78 for the current year and 10.2 for next year, earnings multiples are highly attractive compared with competitors.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
Weaknesses
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+24.33% | 3.3B | C+ | ||
+3.49% | 104B | A- | ||
-8.98% | 60.79B | A- | ||
+82.86% | 51.13B | B | ||
+14.68% | 38.21B | B | ||
-0.68% | 30.75B | A- | ||
+10.20% | 19.83B | B- | ||
+10.56% | 16.5B | C+ | ||
+7.90% | 13.82B | B- | ||
-2.61% | 13.33B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 000830 Stock
- Ratings Luxi Chemical Group Co., Ltd.